<page><tag>3</tag><title>AstraZeneca's Crestor May Harm Kidneys</title><text> WASHINGTON (Reuters) - Twenty-nine patients who took  AstraZeneca Plc's &amp;lt;A HREF="http://www.investor.reuters.com/FullQuote.aspx?ticker=AZN.L target=/stocks/quickinfo/fullquote"&amp;gt;AZN.L&amp;lt;/A&amp;gt; &amp;lt;A HREF="http://www.investor.reuters.com/FullQuote.aspx?ticker=AZN.N target=/stocks/quickinfo/fullquote"&amp;gt;AZN.N&amp;lt;/A&amp;gt; anti-cholesterol drug Crestor  have developed kidney damage, a U.S. consumer group said on  Friday as it called again for a ban on the medicine.</text></page>